X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (59) 59
humans (45) 45
hematology (43) 43
mutation (29) 29
oncology (25) 25
article (18) 18
polycythemia-vera (17) 17
animals (16) 16
male (16) 16
abridged index medicus (15) 15
myeloproliferative neoplasms (14) 14
essential thrombocythemia (13) 13
female (13) 13
mice (13) 13
myelofibrosis (13) 13
aged (12) 12
food and beverages (12) 12
hemic and lymphatic diseases (12) 12
leukemia (12) 12
mutations (12) 12
prognosis (12) 12
adult (11) 11
middle aged (11) 11
myeloid neoplasia (11) 11
somatic mutations (11) 11
acute myeloid-leukemia (10) 10
ruxolitinib (10) 10
janus kinase 2 - genetics (9) 9
therapy (9) 9
treatment outcome (9) 9
genetic aspects (8) 8
leukemia, myeloid, acute - genetics (8) 8
medicine, research & experimental (8) 8
myeloid metaplasia (8) 8
signal transduction (8) 8
tyrosine kinase jak2 (8) 8
acute myeloid leukemia (7) 7
cancer (7) 7
care and treatment (7) 7
expression (7) 7
myelodysplastic syndromes (7) 7
tumors (7) 7
analysis (6) 6
cell biology (6) 6
chronic myelomonocytic leukemia (6) 6
gene mutations (6) 6
hematology, oncology and palliative medicine (6) 6
leukemia, myeloid, acute - therapy (6) 6
myeloproliferative disorders - diagnosis (6) 6
myeloproliferative disorders - drug therapy (6) 6
myeloproliferative disorders - genetics (6) 6
neoplasms (6) 6
primary myelofibrosis (6) 6
classification (5) 5
disease (5) 5
disease progression (5) 5
glycosylation (5) 5
hematopoietic stem (5) 5
leukemia, myeloid, acute - diagnosis (5) 5
leukemic transformation (5) 5
medical colleges (5) 5
medical research (5) 5
medicine, experimental (5) 5
myelodysplastic syndrome (5) 5
myeloproliferative disorders - pathology (5) 5
online only (5) 5
proto-oncogene proteins b-raf - genetics (5) 5
risk assessment (5) 5
signal transduction - drug effects (5) 5
activating mutation (4) 4
activation (4) 4
acute lymphoblastic-leukemia (4) 4
antineoplastic agents - adverse effects (4) 4
antineoplastic agents - therapeutic use (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
available therapy (4) 4
biochemistry & molecular biology (4) 4
cell transformation, neoplastic - genetics (4) 4
children (4) 4
disorders (4) 4
drug therapy (4) 4
erdheim-chester disease (4) 4
fucose - metabolism (4) 4
health aspects (4) 4
hematologic neoplasms - genetics (4) 4
hematopoietic stem cells (4) 4
inhibition (4) 4
jak2 (4) 4
janus kinase 2 - antagonists & inhibitors (4) 4
langerhans cell histiocytosis (4) 4
melanoma (4) 4
membrane proteins - metabolism (4) 4
myeloproliferative disorders - metabolism (4) 4
myeloproliferative neoplasm (4) 4
online only articles (4) 4
primary myelofibrosis - genetics (4) 4
receptors, thrombopoietin - genetics (4) 4
research (4) 4
review (4) 4
stem-cells (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences, ISSN 0027-8424, 12/2014, Volume 111, Issue 50, pp. E5401 - E5410
Journal Article
Cell Reports, ISSN 2211-1247, 12/2014, Volume 9, Issue 5, pp. 1841 - 1855
Journal Article
LEUKEMIA, ISSN 0887-6924, 11/2019, Volume 33, Issue 11, pp. 2753 - 2757
Journal Article
Cancer treatment and research, ISSN 0927-3042, 2019, Volume 179, p. 159
The myeloproliferative neoplasms (MPNs) are clonal stem cell-derived diseases. This chapter focuses on the subcategory of Philadelphia (Ph) chromosome-negative... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1677 - 1677
MPN-BP originates from a leukemic stem cell (LSC) that is capable of recreating and serial passaging the leukemia in NSG mice (Wang Blood 2018). The genomic... 
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 02/2018, Volume 128, Issue 2, pp. 789 - 804
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 5583 - 5583
Background: About 25% of individuals with essential thrombocythemia (ET) harbor a somatic mutation of the cal reticulin (CALR) gene which is thought to be the... 
Journal Article
Annals of Hematology, ISSN 0939-5555, 06/2016, Volume 95, Issue 7, pp. 1197 - 1200
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00277-016-2664-4 
ATYPICAL CML | DIAGNOSIS | CSF3R | HEMATOLOGY | SETBP1 MUTATIONS | Pyrazoles - therapeutic use | Receptors, Colony-Stimulating Factor - genetics | Leukemia, Neutrophilic, Chronic - drug therapy | Humans | Male | Treatment Outcome | Aged | Leukemia, Neutrophilic, Chronic - genetics | Mutation - genetics | Medical colleges | Leukemia
Journal Article
Journal Article
BIOMARKER RESEARCH, ISSN 2050-7771, 07/2019, Volume 7, Issue 1, pp. 15 - 8
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 04/2011, Volume 121, Issue 4, pp. 1255 - 1258
Journal Article